Identification of Novel Gene Targets and Functions of p21-Activated Kinase 1 during DNA Damage by Gene Expression Profiling

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Motwani, Mona ^a   Li, Da Qiang ^b   Horvath, Anelia ^a   Kumar, Rakesh ^a,b  

^a GEORGE WASHINGTON UNIVERSITY   (United States)

^b GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

P21 ACTIVATED KINASE 1; PROTEIN P53; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; CELL CYCLE ARREST; CELL DEATH; CELL STIMULATION; CLASSIFICATION; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; DNA REPLICATION; EMBRYO CELL; FIBROBLAST; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE IDENTIFICATION; GENE TARGETING; GENETIC TRANSCRIPTION; GENOME ANALYSIS; IONIZING RADIATION; MOUSE; MULTIGENE FAMILY; NONHUMAN; NUCLEOTIDE SEQUENCE; PAK1 GENE; RADIATION RESPONSE; SIGNAL TRANSDUCTION; UNINDEXED SEQUENCE;

ANIMALS; CELL LINE; CLUSTER ANALYSIS; DNA DAMAGE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE KNOCKOUT TECHNIQUES; GENE REGULATORY NETWORKS; MICE; MOLECULAR SEQUENCE ANNOTATION; P21-ACTIVATED KINASES; PROTEIN BINDING; RADIATION, IONIZING; REPRODUCIBILITY OF RESULTS; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 84881519374     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0066585     Document Type: Article

References (54)

1. Molli PR, Li DQ, Murray BW, Rayala SK, Kumar R, (2009) PAK signaling in oncogenesis. Oncogene 28: 2545-2555.
2. Bokoch GM, (2003) Biology of the p21-activated kinases. Annu Rev Biochem 72: 743-781.
3. Kumar R, Gururaj AE, Barnes CJ, (2006) p21-activated kinases in cancer. Nat Rev Cancer 6: 459-471.
4. Manser E, Leung T, Salihuddin H, Zhao ZS, Lim L, (1994) A brain serine/threonine protein kinase activated by Cdc42 and Rac1. Nature 367: 40-46.
5. Tsakiridis T, Taha C, Grinstein S, Klip A, (1996) Insulin activates a p21-activated kinase in muscle cells via phosphatidylinositol 3-kinase. J Biol Chem 271: 19664-19667.
6. Bokoch GM, Reilly AM, Daniels RH, King CC, Olivera A, et al. (1998) A GTPase-independent mechanism of p21-activated kinase activation. Regulation by sphingosine and other biologically active lipids. J Biol Chem 273: 8137-8144.
7. Vadlamudi RK, Li F, Barnes CJ, Bagheri-Yarmand R, Kumar R, (2004) p41-Arc subunit of human Arp2/3 complex is a p21-activated kinase-1-interacting substrate. EMBO Rep 5: 154-160.
8. Vadlamudi RK, Li F, Adam L, Nguyen D, Ohta Y, et al. (2002) Filamin is essential in actin cytoskeletal assembly mediated by p21-activated kinase 1. Nat Cell Biol 4: 681-690.
9. Edwards DC, Sanders LC, Bokoch GM, Gill GN, (1999) Activation of LIM-kinase by Pak1 couples Rac/Cdc42 GTPase signalling to actin cytoskeletal dynamics. Nat Cell Biol 1: 253-259.
10. Schurmann A, Mooney AF, Sanders LC, Sells MA, Wang HG, et al. (2000) p21-activated kinase 1 phosphorylates the death agonist bad and protects cells from apoptosis. Mol Cell Biol 20: 453-461.
11. Frost JA, Swantek JL, Stippec S, Yin MJ, Gaynor R, et al. (2000) Stimulation of NFkappa B activity by multiple signaling pathways requires PAK1. J Biol Chem 275: 19693-19699.
12. Vadlamudi RK, Bagheri-Yarmand R, Yang Z, Balasenthil S, Nguyen D, et al. (2004) Dynein light chain 1, a p21-activated kinase 1-interacting substrate, promotes cancerous phenotypes. Cancer Cell 5: 575-585.
13. Singh RR, Song C, Yang Z, Kumar R, (2005) Nuclear localization and chromatin targets of p21-activated kinase 1. J Biol Chem 280: 18130-18137.
14. Li F, Adam L, Vadlamudi RK, Zhou H, Sen S, et al. (2002) p21-activated kinase 1 interacts with and phosphorylates histone H3 in breast cancer cells. EMBO Rep 3: 767-773.
15. Balasenthil S, Sahin AA, Barnes CJ, Wang RA, Pestell RG, et al. (2004) p21-activated kinase-1 signaling mediates cyclin D1 expression in mammary epithelial and cancer cells. J Biol Chem 279: 1422-1428.
16. Li DQ, Nair SS, Ohshiro K, Kumar A, Nair VS, et al. (2012) MORC2 signaling integrates phosphorylation-dependent, ATPase-coupled chromatin remodeling during the DNA damage response. Cell Rep 2: 1657-1669.
17. Ettinger AJ, Feng G, Sanes JR, (1997) epsilon-Sarcoglycan, a broadly expressed homologue of the gene mutated in limb-girdle muscular dystrophy 2D. J Biol Chem 272: 32534-32538.
18. Grabowski M, Zimprich A, Lorenz-Depiereux B, Kalscheuer V, Asmus F, et al. (2003) The epsilon-sarcoglycan gene (SGCE), mutated in myoclonus-dystonia syndrome, is maternally imprinted. Eur J Hum Genet 11: 138-144.
19. Dong H, Ge X, Shen Y, Chen L, Kong Y, et al. (2009) Gene expression profile analysis of human hepatocellular carcinoma using SAGE and LongSAGE. BMC Med Genomics 2: 5.
20. Bauer K, Kratzer M, Otte M, de Quintana KL, Hagmann J, et al. (2000) Human CLP36, a PDZ-domain and LIM-domain protein, binds to alpha-actinin-1 and associates with actin filaments and stress fibers in activated platelets and endothelial cells. Blood 96: 4236-4245.
21. Hong SH, (2005) Identification of CLP36 as a tumor antigen that induces an antibody response in pancreatic cancer. Cancer Res Treat 37: 71-77.
22. Sells MA, Knaus UG, Bagrodia S, Ambrose DM, Bokoch GM, et al. (1997) Human p21-activated kinase (Pak1) regulates actin organization in mammalian cells. Curr Biol 7: 202-210.
23. Dummler BA, Hauge C, Silber J, Yntema HG, Kruse LS, et al. (2005) Functional characterization of human RSK4, a new 90-kDa ribosomal S6 kinase, reveals constitutive activation in most cell types. J Biol Chem 280: 13304-13314.
24. Yntema HG, van den Helm B, Kissing J, van Duijnhoven G, Poppelaars F, et al. (1999) A novel ribosomal S6-kinase (RSK4; RPS6KA6) is commonly deleted in patients with complex X-linked mental retardation. Genomics 62: 332-343.
25. Me LL, Vidal F, Gallardo D, Diaz-Fuertes M, Rojo F, et al. (2006) New p53 related genes in human tumors: significant downregulation in colon and lung carcinomas. Oncol Rep 16: 603-608.
26. Thakur A, Rahman KW, Wu J, Bollig A, Biliran H, et al. (2007) Aberrant expression of X-linked genes RbAp46, Rsk4, and Cldn2 in breast cancer. Mol Cancer Res 5: 171-181.
27. Thakur A, Sun Y, Bollig A, Wu J, Biliran H, et al. (2008) Anti-invasive and antimetastatic activities of ribosomal protein S6 kinase 4 in breast cancer cells. Clin Cancer Res 14: 4427-4436.
28. Anjum R, Blenis J, (2008) The RSK family of kinases: emerging roles in cellular signalling. Nat Rev Mol Cell Biol 9: 747-758.
29. Leis O, Eguiara A, Lopez-Arribillaga E, Alberdi MJ, Hernandez-Garcia S, et al. (2012) Sox2 expression in breast tumours and activation in breast cancer stem cells. Oncogene 31: 1354-1365.
30. Xiang R, Liao D, Cheng T, Zhou H, Shi Q, et al. (2011) Downregulation of transcription factor SOX2 in cancer stem cells suppresses growth and metastasis of lung cancer. Br J Cancer 104: 1410-1417.
31. Tanikawa C, Ri C, Kumar V, Nakamura Y, Matsuda K, (2010) Crosstalk of EDA-A2/XEDAR in the p53 signaling pathway. Mol Cancer Res 8: 855-863.
32. Kawase T, Ohki R, Shibata T, Tsutsumi S, Kamimura N, et al. (2009) PH domain-only protein PHLDA3 is a p53-regulated repressor of Akt. Cell 136: 535-550.
33. Jin HO, Seo SK, Woo SH, Kim ES, Lee HC, et al. (2009) SP600125 negatively regulates the mammalian target of rapamycin via ATF4-induced Redd1 expression. FEBS Lett 583: 123-127.
34. Shrestha Y, Schafer EJ, Boehm JS, Thomas SR, He F, et al. (2012) PAK1 is a breast cancer oncogene that coordinately activates MAPK and MET signaling. Oncogene 31: 3397-3408.
35. Ye DZ, Field J, (2012) PAK signaling in cancer. Cell Logist 2: 105-116.
36. Eswaran J, Li DQ, Shah A, Kumar R, (2012) Molecular pathways: targeting p21-activated kinase 1 signaling in cancer-opportunities, challenges, and limitations. Clin Cancer Res 18: 3743-3749.
37. Hackanson B, Bennett KL, Brena RM, Jiang J, Claus R, et al. (2008) Epigenetic modification of CCAAT/enhancer binding protein alpha expression in acute myeloid leukemia. Cancer Res 68: 3142-3151.
38. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ, (1993) The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75: 805-816.
39. Tamborini E, Della Torre G, Lavarino C, Azzarelli A, Carpinelli P, et al. (2001) Analysis of the molecular species generated by MDM2 gene amplification in liposarcomas. Int J Cancer 92: 790-796.
40. Monte M, Benetti R, Buscemi G, Sandy P, Del Sal G, et al. (2003) The cell cycle-regulated protein human GTSE-1 controls DNA damage-induced apoptosis by affecting p53 function. J Biol Chem 278: 30356-30364.
41. Yang SP, Lee HJ, Su Y, (2005) Molecular cloning and structural characterization of the functional human thymosin beta4 gene. Mol Cell Biochem 272: 97-105.
42. Sanders MC, Goldstein AL, Wang YL, (1992) Thymosin beta 4 (Fx peptide) is a potent regulator of actin polymerization in living cells. Proc Natl Acad Sci U S A 89: 4678-4682.
43. Zhao C, Putnik M, Gustafsson JA, Dahlman-Wright K, (2009) Microarray analysis of altered gene expression in ERbeta-overexpressing HEK293 cells. Endocrine 36: 224-232.
44. Olbryt M, Jarzab M, Jazowiecka-Rakus J, Simek K, Szala S, et al. (2006) Gene expression profile of B 16(F10) murine melanoma cells exposed to hypoxic conditions in vitro. Gene Expr 13: 191-203.
45. Wang WS, Chen PM, Hsiao HL, Wang HS, Liang WY, et al. (2004) Overexpression of the thymosin beta-4 gene is associated with increased invasion of SW480 colon carcinoma cells and the distant metastasis of human colorectal carcinoma. Oncogene 23: 6666-6671.
46. Tatenhorst L, Senner V, Puttmann S, Paulus W, (2004) Regulators of G-protein signaling 3 and 4 (RGS3, RGS4) are associated with glioma cell motility. J Neuropathol Exp Neurol 63: 210-222.
47. Nikolova DN, Zembutsu H, Sechanov T, Vidinov K, Kee LS, et al. (2008) Genome-wide gene expression profiles of thyroid carcinoma: Identification of molecular targets for treatment of thyroid carcinoma. Oncol Rep 20: 105-121.
48. Xie Y, Wolff DW, Wei T, Wang B, Deng C, et al. (2009) Breast cancer migration and invasion depend on proteasome degradation of regulator of G-protein signaling 4. Cancer Res 69: 5743-5751.
49. Vadlamudi RK, Manavathi B, Singh RR, Nguyen D, Li F, et al. (2005) An essential role of Pak1 phosphorylation of SHARP in Notch signaling. Oncogene 24: 4591-4596.
50. Molli PR, Li DQ, Bagheri-Yarmand R, Pakala SB, Katayama H, et al. (2010) Arpc1b, a centrosomal protein, is both an activator and substrate of Aurora A. J Cell Biol 190: 101-114.
51. Li DQ, Pakala SB, Reddy SD, Ohshiro K, Peng SH, et al. (2011) Revelation of p53-independent function of MTA1 in DNA damage response via modulation of the p21 WAF1-proliferating cell nuclear antigen pathway. J Biol Chem 285: 10044-10052.
52. Barrett T, Edgar R, (2006) Gene expression omnibus: microarray data storage, submission, retrieval, and analysis. Methods Enzymol 411: 352-369.
53. Li DQ, Divijendra Natha Reddy S, Pakala SB, Wu X, Zhang Y, et al. (2009) MTA1 coregulator regulates p53 stability and function. J Biol Chem 284: 34545-34552.
54. Li DQ, Ohshiro K, Reddy SD, Pakala SB, Lee MH, et al. (2009) E3 ubiquitin ligase COP1 regulates the stability and functions of MTA1. Proc Natl Acad Sci U S A 106: 17493-17498.